Stories about Miscellaneous

Subscribe to topic
Subscribe to Miscellaneous
Language:
english
Content:
All
Date:
All
Yesterday
Last 7 days
April
Reset
05.01.2018 – 08:03

Takeda Pharmaceutical Company Limited

Takeda Announces Intention to Acquire TiGenix

Osaka, Japan (ots/PRNewswire) - Expands Takeda's Late Stage Pipeline and Leadership in Gastroenterology Acquisition Highlights - Deal reinforces Takeda's commitment to patients living with Inflammatory Bowel Disease (IBD), an area of high unmet medical need - Acquisition extends existing collaboration between Takeda and TiGenix to develop and commercialize Cx601 (darvadstrocel) - On December 15, ...
05.01.2018 – 07:24

Takeda Pharmaceutical Company Limited

Takeda Announces Intention to Acquire TiGenix

Osaka, Japan (ots/PRNewswire) - Expands Takeda's Late Stage Pipeline and Leadership in Gastroenterology Acquisition Highlights - Deal reinforces Takeda's commitment to patients living with Inflammatory Bowel Disease (IBD), an area of high unmet medical need - Acquisition extends existing collaboration between Takeda and TiGenix to develop and commercialize Cx601 (darvadstrocel) - On December 15, ...
14.12.2017 – 13:45
Bayerische Zugspitzbahn Bergbahn AG: Zugspitze: New record-breaking cable car to the Top of Germany
1

Bayerische Zugspitzbahn Bergbahn AG

Zugspitze: New record-breaking cable car to the Top of Germany

Garmisch-Partenkirchen (ots) - The cable car's inaugural journey on December 21st 2017 will mark the beginning of a new era: one in which the state of the art cable car Zugspitze whisks passengers up to the highest mountain in the country in unparalleled comfort. Six years in total of planning and construction work, sometimes under the most challenging of conditions at 3,000 metres above sea level, have been invested in this superlative project and resulted in an ...
18.12.2017 – 11:00

epi24 GmbH

"ORGASM IS A HUMAN RIGHT"

Berlin (ots) - Video Content: https://goo.gl/qpgLG3 It´s no secret that women have fewer orgasms than men. A new large-scale study[1] has shown how big the existing "orgasm gap" still is: 35% of all women rarely have an orgasm, or never do. For men, this figure is only 5%. The womanizer® brand, using Pleasure Air Technology®, has set out to change this. The #OrgasmIsAHumanRight campaign An orgasm is a beautiful, unique event, and every ...
22.11.2017 – 01:37

ViiV Healthcare

Juluca® (Dolutegravir and Rilpivirine) Approved in US as First 2-drug Regimen, Once-daily, Single Pill - a Complete Regimen for the Maintenance Treatment of Virologically Suppressed HIV-1 Infection

London (ots/PRNewswire) - ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) has approved Juluca®, indicated as a complete regimen for the maintenance treatment ...